Investor Presentaiton

India Branded Generic Business Focus on 4 Therapeutic Segments ajanta Cardiology Ophthalmology Dermatology Pain Management Growth continues 2nd largest in India Outperforming IPM Gained 2 ranks India - Higher than Industry Growth 25% IPM-Indian Pharmaceutical Market Source: Iqvia, September MAT 2022 20% 15% 14% 10% 7% 6% 5% 90 10% 15% 14% 3% 20% 19% 13% Pharma Market Cardiology Ophthalmology Dermatology Pain Management IPM Ajanta Pharma 9 of 37 ajanta 10 of 37 5

View entire presentation